Profilo
John Hayslip currently works at Verastem, Inc., as Chief Medical Officer from 2024.
Dr. Hayslip also formerly worked at The Markey Cancer Center Foundation, as Director-Clinical Research & Data Management, Nektar Therapeutics, as Vice President-Clinical Development, and I-Mab, as Chief Medical Officer from 2022 to 2024.
Dr. Hayslip received his graduate degree from The Medical University of South Carolina and doctorate degree from Northeast Ohio Medical University.
Posizioni attive di John Hayslip
| Società | Posizione | Inizio |
|---|---|---|
| VERASTEM, INC. | Direttore Tecnico/Scientifico/R&S | 18/04/2024 |
Precedenti posizioni note di John Hayslip
| Società | Posizione | Fine |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Direttore Tecnico/Scientifico/R&S | 15/04/2024 |
The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | - |
Formazione di John Hayslip
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Markey Cancer Center Foundation | |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Northeast Ohio Medical University
Northeast Ohio Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
















